Ermium Therapeutics
Paris, France-based biotech company
Ermium Therapeutics has raised €6.3M across 1 funding round from 2 investors, most recently a round in Jul 2022. Based in Paris, France; active in Healthtech. Data as of 4 Nov 2026.
Paris, Francewww.ermium.com ↗
Total raised
€6.3M
€6,300,000
Funding rounds
1
Investors
2
distinct backers
Active since
2022-07
latest 2022-07
Funding by year
EUR raised per yearErmium Therapeutics — funding by year — interactive chart.
Data table
| Ermium Therapeutics — funding by year | |
|---|---|
| 2022 | €6.3M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-07-04 | Other | €6.3M | Fountain Healthcare Partners,Kurma Partners | View deal → |
Related news
- Ermium Therapeutics Raises Further €6M in Funding; Brings Total to €12.3Mfinsmes.com · 2022-07
Similar companies
same sector, similar size- Dianosic€6.2MFrance · Healthtech
- AcuSurgical€5.8MFrance · Healthtech
- BrainTale€5.5MFrance · Healthtech
- i-Virtual€5.5MFrance · Healthtech
- Omnidoc€6.0MFrance · Healthtech
- Vect-Hours€6.7MFrance · Healthtech
Global coverage: FundingData